Valuation: Repligen Corporation

Market Cap 10.06B 8.98B 8.34B 7.59B 14.28B 953B 14.54B 100B 39.21B 497B 37.74B 36.94B 1,590B P/E 2026 *
242x
P/E 2027 * 111x
Enterprise Value 10.03B 8.95B 8.32B 7.57B 14.24B 950B 14.49B 99.94B 39.1B 496B 37.63B 36.84B 1,586B EV / Sales 2026 *
12x
EV / Sales 2027 * 9.16x
Free-Float
94.95%
Yield 2026 *
-
Yield 2027 * -
1 day+3.66%
1 week+12.51%
Current month-4.10%
1 month+5.50%
3 months+24.50%
6 months+39.73%
Current year+12.50%
1 week 164.21
Extreme 164.21
185.4
1 month 157.44
Extreme 157.4355
198.87
Current year 100.99
Extreme 100.99
198.87
1 year 100.99
Extreme 100.99
198.87
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
306.98
10 years 26.16
Extreme 26.16
327.32
Manager TitleAgeSince
Chief Executive Officer 56 01/09/2024
Director of Finance/CFO 52 25/09/2023
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Director/Board Member 60 12/06/2014
Director/Board Member 67 01/10/2015
Director/Board Member 61 01/03/2020
Date Insider Type Main position Quantity % Market Cap. Importance
6/10/26 Free

Executive/Senior Manager

1,375 0.0024%
5/10/26 Sell

Chief Executive Officer

-13,939 0.0247%
2/10/26 Tax

Chief Executive Officer

-1,248 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
+3.69%+12.51%+23.29%+20.36% 10.06B
+2.31%+6.27%-19.14%+13.55% 178B
+1.43%+8.79%+0.13%+33.05% 121B
+4.01%+5.70%-20.82%+10.86% 108B
+0.41%+3.99%-44.97%-10.22% 75.7B
+1.61%+6.20%+6.78%+82.63% 64.15B
-1.75%-0.72%+17.66%+59.66% 53.49B
+2.13%+5.72%+3.45%-25.62% 51.45B
+2.75%+5.94%-14.95%+26.56% 41.68B
+3.33%+2.23%+31.92%+9.30% 31.5B
Average +2.01%+4.54%-1.67%+22.01% 73.48B
Weighted average by Cap. +1.95%+4.41%-9.36%+21.20%

Financials

2026 *2027 *
Net sales 833M 744M 691M 629M 1.18B 78.93B 1.2B 8.3B 3.25B 41.18B 3.13B 3.06B 132B 1.08B 965M 896M 815M 1.53B 102B 1.56B 10.77B 4.21B 53.4B 4.06B 3.97B 171B
Net income 42.08M 37.56M 34.91M 31.75M 59.74M 3.99B 60.82M 419M 164M 2.08B 158M 155M 6.65B 102M 91.42M 84.96M 77.28M 145M 9.7B 148M 1.02B 399M 5.06B 384M 376M 16.2B
Net Debt -28.18M -25.16M -23.38M -21.27M -40.01M -2.67B -40.73M -281M -110M -1.39B -106M -104M -4.46B -157M -140M -130M -118M -223M -14.86B -227M -1.56B -612M -7.75B -589M -576M -24.8B
Projected Income Statement - Annual - Repligen Corporation
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
16/10/26 US$184.42 +3.49% 522,899
14/10/26 US$178.20 +1.58% 1,216,922
13/10/26 US$175.42 +1.69% 1,259,264
12/10/26 US$172.51 -0.79% 899,606
09/10/26 US$173.88 +6.13% 1,339,917
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Repligen Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
178.20USD
Average target price
197.95USD
Spread / Average Target
+11.08%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Repligen Corporation
  1. Stock Market
  2. Stocks
  3. RGEN Stock